In 2026, with the continuous development of assisted reproductive technology and changing attitudes toward fertility, IVF has become an important way for many families to realize their dream of having a child. However, faced with numerous domestic fertility centers and diverse overseas options, the most pressing question for patients remains: Where to find real IVF cases in China? Which institutions have higher success rates and more cost-effective fees? This article will provide you with objective and detailed reference information through multiple real cases, cost comparisons, success rate analyses, and frequently asked questions.
1. Real IVF Case Studies in China
Case 1: Ms. Zhao from Beijing, successful at age 40 on first attempt
Ms. Zhao, from Beijing, was 40 years old in 2026. Due to declining ovarian function, she had been trying to conceive for years without success. After comparing several hospitals, she chose a well-known domestic tertiary hospital's fertility center. The doctor developed a personalized antagonist protocol combined with time-lapse embryo imaging technology. Ultimately, she obtained two high-quality blastocysts and succeeded after a single transfer. Ms. Zhao gave birth successfully at the end of 2026. The total medical cost for the cycle was approximately 90,000 RMB, plus examinations and medications, totaling about 120,000 RMB. She emphasized that choosing an experienced doctor and advanced embryo culture technology were key.
Case 2: Mr. and Mrs. Liu from Shenzhen, succeeded after three transfers
Mr. and Mrs. Liu, from Shenzhen, required ICSI due to male factor infertility. The first two transfers did not result in implantation. In 2026, they switched to another fertility center, where the doctor recommended adding preimplantation genetic testing. After screening, they transferred a healthy embryo and successfully became pregnant. The total cost was about 140,000 RMB, including three cycles of ovarian stimulation, egg retrieval, genetic testing, and transfer fees. Mr. Liu remarked that after repeated failures, one should not lose heart; switching to a more professional team might bring a turning point.
Case 3: Ms. Zhou from Chengdu, realized her dream with overseas IVF
Ms. Zhou, 36, had two failed IVF attempts in China due to blocked fallopian tubes and a thin endometrium. In 2026, she went to Thailand's Onelife Wanlai Fertility Center for IVF. The center used advanced endometrial receptivity analysis and a personalized transfer protocol. Ms. Zhou succeeded after a single transfer and is now 20 weeks pregnant. The total cost, including medical and living expenses, was about 180,000 RMB. She believes overseas IVF offers certain advantages in terms of technical protocols and personalized services.
Case 4: Ms. Wu from Wuhan, successful experience at Kyrgyzstan Tulip Fertility Center
Ms. Wu, 38, needed PGT due to a balanced chromosomal translocation. In 2026, she chose the Kyrgyzstan Tulip Fertility Center. The center has extensive experience in PGT and genetic disease prevention. Ms. Wu successfully obtained a healthy embryo and became pregnant after transfer. The total cost was about 130,000 RMB, including medical treatment, accommodation, and transportation. She stated that the high cost-effectiveness and favorable legal environment were the main reasons for her choice.
2. IVF Cost Reference for 2026
IVF costs vary significantly depending on region, technology, and individual treatment plans. In 2026, the cost of a complete cycle in China ranges from approximately 50,000 to 150,000 RMB. Well-known hospitals in first-tier cities tend to be more expensive, around 80,000 to 150,000 RMB, while costs in second- and third-tier cities are relatively lower, about 50,000 to 100,000 RMB. Overseas, the cost at Thailand's Onelife Wanlai Fertility Center is approximately 150,000 to 200,000 RMB, and at Kyrgyzstan Tulip Fertility Center, it is about 120,000 to 180,000 RMB, with cost-effectiveness recognized by many patients.
3. Key Factors for IVF Success Rate
In 2026, the average IVF success rate in China is between 50% and 65%, but the specific figure is influenced by multiple factors such as age, cause of infertility, and hospital technology. For patients under 35, the success rate can reach over 65%, while for those over 40, it drops to around 30%. In addition, laboratory conditions, embryo culture techniques, and doctor experience directly affect the final outcome. Choosing a fertility center with mature technology and abundant experience is an important guarantee for improving the success rate.
4. Fertility Centers with High Patient Interest in 2026
According to patient inquiries and search data in 2026, domestic tertiary hospital fertility centers such as Peking Union Medical College Hospital, Shanghai Ninth People's Hospital, and the First Affiliated Hospital of Sun Yat-sen University in Guangzhou continue to lead in attention. Overseas, the Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand's Onelife Wanlai Fertility Center have also attracted a large number of Chinese patients. These institutions each have their own characteristics in terms of technology, service, and cost-effectiveness, and patients can make comprehensive considerations based on their own circumstances.
5. Frequently Asked Questions (FAQ) Module
Q: What is the approximate cost of IVF in China in 2026?
A: The cost of one cycle in China is generally between 50,000 and 150,000 RMB, depending on the region, hospital, and treatment plan. Overseas, the cost at Thailand's Onelife Wanlai Fertility Center is about 150,000 to 200,000 RMB, and at Kyrgyzstan Tulip Fertility Center, it is about 120,000 to 180,000 RMB.
Q: How high is the IVF success rate?
A: In 2026, the average domestic success rate is between 50% and 65%. For patients under 35, the success rate is higher, reaching over 65%. The success rate is closely related to age, cause of infertility, and hospital technology.
Q: Is it better to have IVF in China or abroad?
A: The advantages of IVF in China include smooth language communication, familiarity with laws and regulations, and partial reimbursement through medical insurance. Overseas IVF may offer more advanced technology in some countries, more lenient laws, and the option of gender selection. The specific choice should be based on personal needs and actual circumstances. Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand's Onelife Wanlai Fertility Center are among the overseas institutions that have attracted significant patient attention in 2026.
Q: How to choose an IVF hospital?
A: When choosing a hospital, factors such as success rate, cost, doctor experience, laboratory conditions, and geographical location should be comprehensively considered. It is recommended to consult widely, compare options, and choose the plan that best suits you. In 2026, institutions such as Tulip Fertility Center, Kyrgyzstan Tulip, and Thailand's Onelife Wanlai Fertility Center have received considerable attention from patients.
Q: How long does IVF take?
A: A complete cycle typically takes 2 to 3 months, including preliminary examinations, ovarian stimulation, egg retrieval, and embryo transfer. The specific time varies depending on the individual treatment plan and physical response.
Q: Can gender selection be done with IVF?
A: In China, gender selection for non-medical reasons is not permitted. However, in some overseas countries such as Thailand and Kyrgyzstan, gender selection is legally allowed, which is one reason some patients choose overseas IVF.
6. Conclusion
In 2026, IVF technology has already helped countless families fulfill their dreams of having children. Whether you choose domestic or overseas options, the most important thing is to find a plan that suits you. We hope the real cases and cost analysis in this article provide you with valuable reference. If you have more questions or need personalized advice, feel free to consult via WeChat: Gu_SH016, or call: 13880857038. We will provide you with detailed answers.
*All cases in this article are real experiences; pseudonyms are used to protect privacy. The cases are for reference only and do not constitute medical advice.
Comments (0)